CLASS III Drug recall · Reported 4 Jan 2023 · FDA Enforcement Report

Timolol Maleate Ophthalmic Solution recalled by Apotex

Apotex is recalling Timolol Maleate Ophthalmic Solution, USP 0.5%, distributed nationwide in the US. The recall was initiated on 21 Dec 2022 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot# TA4844, Exp 03/2023
Quantity recalled22,027 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0093-2023
FDA event ID
91353
Recalling firm
Apotex, Weston, FL
Classification
Class III
Status
Terminated
Recall initiated
21 Dec 2022
FDA classified
28 Dec 2022
Reported
4 Jan 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay
Drug class
Eye Drops

Timeline

21 Dec 2022Recall initiated by company
28 Dec 2022Classified by FDA+7 days
4 Jan 2023Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Timolol Maleate Ophthalmic Solution, USP 0.5%, 2.5 mL, Rx Only, Mfg by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Mfg for: Apotex Corp. Weston, FL 33326, NDC 60505-1005-4

Where it was distributed

USA Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.

Which lots are affected?

Lot# TA4844, Exp 03/2023

Where was it sold?

USA Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Apotex

All 76
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIParoxetine Extended-Release Tablets, 37.5mg recalled by ApotexParoxetine HydrochlorideApotexPotency & AssayNationwide
DrugCLASS IIPaxil CR, Paroxetine, Extended-Release Tablets, 37.5mg recalledApotexPotency & AssayNationwide
DrugCLASS IIDesmopressin Nasal Spray, USP, 10 mcg/ bottle (50 doses) recalledApotexOtherNationwide
DrugCLASS IIBrimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%* recalledBrimonidine Tartrate/timolol Maleate Ophthalmic SolutionApotexSterilityNationwide
DrugCLASS IIKetorolac Tromethamine Ophthalmic Solution recalled by ApotexKetorolac TromethamineApotexSterilityNationwide

Other Timolol recalls

All 20
ReportedClassRecallCompanyReasonWhere
DrugCLASS IITimolol Maleate Ophthalmic Solution USP, 0.5%, Sterile recalled by FDCTimolol MaleateFDCOtherNationwide
DrugCLASS IITimolol Maleate Ophthalmic Solution USP, 0.5%, Sterile recalled by FDCTimolol MaleateFDCOtherNationwide
DrugCLASS IITimolol Maleate Ophthalmic Solution USP, 0.5%, Sterile recalled by FDCTimolol MaleateFDCOtherNJ
DrugCLASS IITimolol Maleate Ophthalmic Solution USP, 0.25%, Sterile recalled by FDCTimolol MaleateFDCOtherNJ
DrugCLASS IITimolol Maleate Ophthalmic Solution USP, 0.5%, Sterile recalled by FDCTimolol MaleateFDCOtherNJ